Cargando…

Recommendations for the Reporting of Harms in Manuscripts on Clinical Trials Assessing Osteoarthritis Drugs: A Consensus Statement from the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO)

BACKGROUND: There is strong evidence of under-reporting of harms in manuscripts on randomized controlled trials (RCTs) compared with the volume of raw data retrieved from these trials. Many guidelines have been developed to tackle this, but they have failed to address some important issues that woul...

Descripción completa

Detalles Bibliográficos
Autores principales:	Honvo, Germain, Bannuru, Raveendhara R., Bruyère, Olivier, Rannou, Francois, Herrero-Beaumont, Gabriel, Uebelhart, Daniel, Cooper, Cyrus, Arden, Nigel, Conaghan, Philip G., Reginster, Jean-Yves, Thomas, Thierry, McAlindon, Tim
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2019
Materias:	Leading Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6509216/ https://www.ncbi.nlm.nih.gov/pubmed/31073927 http://dx.doi.org/10.1007/s40266-019-00667-8

Ejemplares similares

Safety of Intra-articular Hyaluronic Acid Injections in Osteoarthritis: Outcomes of a Systematic Review and Meta-Analysis
por: Honvo, Germain, et al.
Publicado: (2019)

Importance of Safety in the Management of Osteoarthritis and the Need for Updated Meta-Analyses and Recommendations for Reporting of Harms
por: Reginster, Jean-Yves, et al.
Publicado: (2019)

Safety of Oral Non-Selective Non-Steroidal Anti-Inflammatory Drugs in Osteoarthritis: What Does the Literature Say?
por: Cooper, Cyrus, et al.
Publicado: (2019)

Use of Intraarticular Hyaluronic Acid in the Management of Knee Osteoarthritis in Clinical Practice
por: Cooper, Cyrus, et al.
Publicado: (2017)

Inappropriate claims from non-equivalent medications in osteoarthritis: a position paper endorsed by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO)
por: Bruyère, Olivier, et al.
Publicado: (2017)

Safety of Opioids in Osteoarthritis: Outcomes of a Systematic Review and Meta-Analysis
por: Fuggle, Nicholas, et al.
Publicado: (2019)

Update on the role of pharmaceutical-grade chondroitin sulfate in the symptomatic management of knee osteoarthritis
por: Honvo, Germain, et al.
Publicado: (2019)

Diacerein: Benefits, Risks and Place in the Management of Osteoarthritis. An Opinion-Based Report from the ESCEO
por: Pavelka, Karel, et al.
Publicado: (2016)

The incidence and characteristics of accelerated knee osteoarthritis among women: the Chingford cohort
por: Driban, Jeffrey B., et al.
Publicado: (2020)

Health Economic Evaluation of a High and Low Molecular Weight Hyaluronic Acid Formulation for the Treatment of Knee Osteoarthritis. Post Hoc Analyses from a Randomized Clinical Trial
por: Bruyère, Olivier, et al.
Publicado: (2022)

Can We Identify Patients with High Risk of Osteoarthritis Progression Who Will Respond to Treatment? A Focus on Epidemiology and Phenotype of Osteoarthritis
por: Bruyère, Olivier, et al.
Publicado: (2015)

Cost-effectiveness evaluation of glucosamine for osteoarthritis based on simulation of individual patient data obtained from aggregated data in published studies
por: Bruyère, Olivier, et al.
Publicado: (2019)

Role of Collagen Derivatives in Osteoarthritis and Cartilage Repair: A Systematic Scoping Review With Evidence Mapping
por: Honvo, Germain, et al.
Publicado: (2020)

Efficacy and safety of duloxetine in osteoarthritis: a systematic review and meta-analysis
por: Osani, Mikala C., et al.
Publicado: (2019)

Publication outcomes of the abstracts presented at the 2011 European Congress on Osteoporosis, Osteoarthritis and Musculo-Skeletal Diseases (ECCEO-IOF11): A position paper of the European Society for Clinical and Economical Aspects of Osteoporosis, Osteoarthritis and Musculo-Skeletal Diseases (ESCEO) and the International Osteoporosis and Other Skeletal Diseases Foundation (IOF)
por: Rabenda, Véronique, et al.
Publicado: (2015)

Efficacy of Chondroitin Sulfate in Patients with Knee Osteoarthritis: A Comprehensive Meta-Analysis Exploring Inconsistencies in Randomized, Placebo-Controlled Trials
por: Honvo, Germain, et al.
Publicado: (2019)

Vitamin D supplementation in the prevention and management of major chronic diseases not related to mineral homeostasis in adults: research for evidence and a scientific statement from the European society for clinical and economic aspects of osteoporosis and osteoarthritis (ESCEO)
por: Cianferotti, Luisella, et al.
Publicado: (2017)

Safety of Symptomatic Slow-Acting Drugs for Osteoarthritis: Outcomes of a Systematic Review and Meta-Analysis
por: Honvo, Germain, et al.
Publicado: (2019)

Safety of Topical Non-steroidal Anti-Inflammatory Drugs in Osteoarthritis: Outcomes of a Systematic Review and Meta-Analysis
por: Honvo, Germain, et al.
Publicado: (2019)

Knee osteoarthritis and adverse health outcomes: an umbrella review of meta-analyses of observational studies
por: Veronese, Nicola, et al.
Publicado: (2022)

Experts’ preferences for sarcopenia outcomes: a discrete-choice experiment from a working group of the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) in collaboration with the European Union of Geriatric Medicine Society (EUGMS)
por: Beaudart, Charlotte, et al.
Publicado: (2021)

Real-world evidence: new opportunities for osteoporosis research. Recommendations from a Working Group from the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO)
por: Moon, Rebecca J., et al.
Publicado: (2023)

Safety of Cyclooxygenase-2 Inhibitors in Osteoarthritis: Outcomes of a Systematic Review and Meta-Analysis
por: Curtis, Elizabeth, et al.
Publicado: (2019)

Management of hand osteoarthritis: from an US evidence-based medicine guideline to a European patient-centric approach
por: Fuggle, Nicholas, et al.
Publicado: (2022)

Multimodal Multidisciplinary Management of Patients with Moderate to Severe Pain in Knee Osteoarthritis: A Need to Meet Patient Expectations
por: Veronese, Nicola, et al.
Publicado: (2022)

Role of vitamin D supplementation in the management of musculoskeletal diseases: update from an European Society of Clinical and Economical Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) working group
por: Chevalley, Thierry, et al.
Publicado: (2022)

Treat-to-target strategy for knee osteoarthritis. International technical expert panel consensus and good clinical practice statements
por: Migliore, Alberto, et al.
Publicado: (2019)

World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2021)
Publicado: (2022)

World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2022)
Publicado: (2022)

Assessment of the Response Profile to Hyaluronic Acid Plus Sorbitol Injection in Patients with Knee Osteoarthritis: Post-Hoc Analysis of a 6-Month Randomized Controlled Trial
por: Bruyère, Olivier, et al.
Publicado: (2021)

Is the Rate of Responders to Hyaluronic Acid Injection for Patients with Knee Osteoarthritis Stable Over Time? Post hoc Analyses of a 6-Month Follow-Up Study
por: Bruyere, Olivier, et al.
Publicado: (2023)

Radiofrequency echographic multi-spectrometry for the in-vivo assessment of bone strength: state of the art—outcomes of an expert consensus meeting organized by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO)
por: Diez-Perez, Adolfo, et al.
Publicado: (2019)

Practical guidance for engaging patients in health research, treatment guidelines and regulatory processes: results of an expert group meeting organized by the World Health Organization (WHO) and the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO)
por: de Wit, Maarten, et al.
Publicado: (2019)

World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases – the “Wco-iof-esceo Congress”: The 18th edition of the WCO-IOF-ESCEO Congress – Krakow 2018
por: Maślińska, Maria
Publicado: (2018)

World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2022): Frontmatter
Publicado: (2022)

Early Osteoarthritis Questionnaire (EOAQ): a tool to assess knee osteoarthritis at initial stage
por: Migliore, Alberto, et al.
Publicado: (2023)

Vitamin D status correction in Saudi Arabia: an experts’ consensus under the auspices of the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis, and Musculoskeletal Diseases (ESCEO)
por: Al-Daghri, Nasser M., et al.
Publicado: (2016)

Author’s failure to read and follow instructions leads to increased trauma to their manuscripts
por: Jawaid, Shaukat Ali, et al.
Publicado: (2018)

Update on the ESCEO recommendation for the conduct of clinical trials for drugs aiming at the treatment of sarcopenia in older adults
por: Reginster, Jean-Yves, et al.
Publicado: (2020)

World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2020): Poster Abstracts
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_qvqmvc8h5dc7ijavkv3ghkcp40